SEPTInvestingStart Free
Stocks/TRVI/SEC Filings/10-Q Nov 9, 2026

TRVI 10-Q: SEC filing

Trevi Therapeutics

Filed with the SEC on Nov 9, 2026 · accession 0001193125-26-453674

TRVI filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. Trevi Therapeutics filed its quarterly report on Form 10-Q for the period ending September 30, 2026, reporting financial results and corporate updates. The stock moved +6.8% by the first close after the filing.

Summary of the filing

Trevi Therapeutics filed its quarterly report on Form 10-Q for the period ending September 30, 2026, reporting financial results and corporate updates. The filing includes standard financial statements, equity compensation details, and disclosures regarding its ongoing operations.

For details, click here →How to read a 10-Q →

Key details

FilerTrevi Therapeutics, Inc.

How TRVI stock reacted

Close before

$14.33

Nov 6, 2026

First close after

+6.84%

$15.31

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for TRVI, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TRVI?

Click here

Frequently asked questions

What did TRVI file with the SEC on Nov 9, 2026?

TRVI filed a 10-Q (SEC filing). Trevi Therapeutics filed its quarterly report on Form 10-Q for the period ending September 30, 2026, reporting financial results and corporate updates. The filing includes standard financial statements, equity compensation details, and disclosures regarding its ongoing operations.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did TRVI stock react to this filing?

TRVI closed at $14.33 before the filing and $15.31 on Nov 9, 2026 (+6.84%).

Other TRVI SEC filings

  • 8-K · SEC filingNov 9, 2026
  • SCHEDULE 13G/A · SEC filingOct 27, 2026
  • 10-Q · SEC filingAug 6, 2026
  • 8-K · SEC filingAug 6, 2026
  • 8-K · SEC filingJun 4, 2026
  • 10-Q · SEC filingMay 5, 2026
  • 8-K · SEC filingMay 5, 2026
  • DEF 14A · Board changeApr 21, 2026
  • 8-K · Secondary offeringApr 17, 2026
  • 424B5 · Secondary offeringApr 17, 2026

Get alerts when TRVI files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
TRVI overviewTRVI analysisTRVI newsLatest SEC filings
Source: SEC EDGAR filing 0001193125-26-453674. The summary and key details are extracted by SEPT from the filing and may contain errors. Price reaction uses daily closing prices. Not financial advice.